Innovator Ibd 50 Etf Profile

FFTY Etf  USD 29.14  0.03  0.10%   

Performance

5 of 100

 
Weak
 
Strong
Modest

Odds Of Distress

Less than 9

 
High
 
Low
Low
Innovator IBD is trading at 29.14 as of the 30th of January 2025; that is 0.1 percent decrease since the beginning of the trading day. The etf's open price was 29.17. Innovator IBD has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat modest performance during the last 90 days. The performance scores are derived for the period starting the 10th of February 2023 and ending today, the 30th of January 2025. Click here to learn more.
The fund will normally invest at least 80 percent of its net assets in securities that comprise the index. Innovator Ibd is traded on NYSEARCA Exchange in the United States. More on Innovator IBD 50

Moving together with Innovator Etf

  0.92VOT Vanguard Mid CapPairCorr
  0.94IWP iShares Russell MidPairCorr
  0.83ARKK ARK Innovation ETF Sell-off TrendPairCorr
  0.77IJK iShares SP MidPairCorr
  0.85JKH iShares Morningstar MidPairCorr
  0.92KOMP SPDR Kensho NewPairCorr

Innovator Etf Highlights

Thematic Ideas
(View all Themes)
Business ConcentrationStrategy ETFs, Broad Equity ETFs, Mid-Cap Growth, Innovator ETFs (View all Sectors)
IssuerInnovator Capital Management
Inception Date2015-04-09
BenchmarkIBD 50 Index
Entity TypeRegulated Investment Company
Asset Under Management75.95 Million
Average Trading Valume115,126.3
Asset TypeEquity
CategoryBroad Equity
FocusStrategy
Market ConcentrationBlended Development
RegionGlobal
AdministratorU.S. Bancorp Fund Services, LLC
AdvisorInnovator Capital Management, LLC
CustodianU.S. Bank, N.A.
DistributorForeside Fund Services, LLC
Portfolio ManagerDustin Lewellyn, Ernesto Tong, Anand Desai
Transfer AgentU.S. Bancorp Fund Services, LLC
Fiscal Year End31-Oct
ExchangeNYSE Arca, Inc.
Number of Constituents50.0
Market MakerVirtu Financial
Total Expense1.09
Management Fee0.7
Country NameUSA
Returns Y T D(0.7)
NameInnovator IBD 50 ETF
Currency CodeUSD
Open FigiBBG008G60GX9
In Threey Volatility29.06
1y Volatility26.48
200 Day M A27.7643
50 Day M A30.1884
CodeFFTY
Updated At30th of January 2025
Currency NameUS Dollar
Innovator IBD 50 [FFTY] is traded in USA and was established 2015-04-08. The fund is listed under Mid-Cap Growth category and is part of Innovator ETFs family. The entity is thematically classified as Strategy ETFs. Innovator IBD 50 currently have 97.73 M in assets under management (AUM). , while the total return for the last 3 years was -6.7%.
Check Innovator IBD Probability Of Bankruptcy

Geographic Allocation (%)

Sector Allocation

Investors will always prefer to have their portfolios divercified against different sectors. The broad sector allocation increases the possibility of making a profit or at least avoiding a loss. However, this may also reduce the expected return on Innovator Etf. Generally, it depends on diversification level and type but usually, the broader the sector allocation, the less risk can be expected from holding Innovator Etf, and the less return is expected.
Institutional investors that are interested in enforcing a sector tilt in their portfolio can use exchange-traded funds, such as Innovator IBD 50 Etf, as a low-cost alternative to building a custom portfolio. So, using sector ETFs to diversify your portfolio can be a profitable strategy. However, no matter what sectors are desirable at a given time, no single industry should ever make up more than 20 percent of your stock portfolio.

Top Innovator IBD 50 Etf Constituents

TERTeradyneStockInformation Technology
OLEDUniversal DisplayStockInformation Technology
CRCTCricut IncStockInformation Technology
WGOWinnebago IndustriesStockConsumer Discretionary
ANETArista NetworksStockInformation Technology
WINGWingstopStockConsumer Discretionary
CPRTCopart IncStockIndustrials
EBSEmergent BiosolutionsStockHealth Care
More Details

Innovator IBD Top Holders

ADOAXAcm Dynamic OpportunityMutual FundOptions Trading
ADOIXAcm Dynamic OpportunityMutual FundOptions Trading
NAVFXThe Sector RotationMutual FundLarge Blend
More Details

Innovator IBD 50 Risk Profiles

The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Innovator IBD. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures.

Innovator IBD Against Markets

When determining whether Innovator IBD 50 offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Innovator IBD's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Innovator Ibd 50 Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Innovator Ibd 50 Etf:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Innovator IBD 50. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
The market value of Innovator IBD 50 is measured differently than its book value, which is the value of Innovator that is recorded on the company's balance sheet. Investors also form their own opinion of Innovator IBD's value that differs from its market value or its book value, called intrinsic value, which is Innovator IBD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Innovator IBD's market value can be influenced by many factors that don't directly affect Innovator IBD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Innovator IBD's value and its price as these two are different measures arrived at by different means. Investors typically determine if Innovator IBD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Innovator IBD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.